Review International journal of molecular sciences · 2024 Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy. Guevara-Ramírez P, Cadena-Ullauri S, Paz-Cruz E, et al. Escherichia coliFaecalibacterium PubMed ↗
European journal of medical research · 2025 Mucosal barrier injury as an independent risk factor for laboratory-confirmed bloodstream infection in patients with hematological malignancies: a real-world study. Liu M, Jiang X, Pi Y, et al. Klebsiella pneumoniae PubMed ↗
Frontiers in cellular and infection microbiology · 2024 Refining the relationship between gut microbiota and common hematologic malignancies: insights from a bidirectional Mendelian randomization study. Chen P, Guo J, Wang W, et al. Agathobacter rectalisAnaerobutyricum halliiBlautia PubMed ↗
Clinical laboratory · 2021 Exploring the Characteristics of Intestinal Microbiota in Hematologic Malignancy Patients via 16s rDNA High-Throughput Sequencing. Pei Z, Xiaowei W, Yajuan L, et al. Collinsella aerofaciensPhocaeicola plebeius PubMed ↗
Randomized trial British journal of haematology · 2019 Pilot study investigating the effect of enteral and parenteral nutrition on the gastrointestinal microbiome post-allogeneic transplantation. Andersen S, Staudacher H, Weber N, et al. Faecalibacterium prausnitziiBlautia PubMed ↗